Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb;22(2):319-322.
doi: 10.3201/eid2202.151332.

Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin

Collaborators

Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin

Margaret M Williams et al. Emerg Infect Dis. 2016 Feb.

Abstract

A Bordetella pertussis strain lacking 2 acellular vaccine immunogens, pertussis toxin and pertactin, was isolated from an unvaccinated infant in New York State in 2013. Comparison with a French strain that was pertussis toxin-deficient, pertactin wild-type showed that the strains carry the same 28-kb deletion in similar genomes.

Keywords: Bordetella pertussis; Pertussis; pertactin; pertussis toxin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Western blot of pertussis toxin (Pt) expression in Bordetella pertussis Tohama I, I979, FR3749, and 3 additional recent isolates. All isolate lanes were loaded with 10-μg of protein, extracted after growth for 48 hours. Protein was transferred with the iBlot Dry Blotting system (Invitrogen, Carlsbad, CA, USA). The primary antibody consisted of 1b7 anti-PTX S1 monoclonal antibody at a concentration of 20 μg/mL diluted in 0.01 M PBS/Tween with 5% milk. The secondary antibody was a FITC-conjugated goat anti-mouse pAb from AbCam, diluted 1:1,000 with 0.01 M PBS/Tween with 5% milk. Lane 1, benchmark protein ladder, 6–180 kDa (Life Technologies, Grand Island, NY, USA); lane 2, Pt positive control, 2 μg; lane 3, empty; lanes 4 and 5, J024 (pertactin (Prn)+/Pt+); lanes 6 and 7, I979 (Prn-/Pt-); lanes 8 and 9, Tohama I (Prn+/Pt+); lanes 10 and 11, I978 (Prn-/Pt+); lanes 12 and 13, FR3749 (Prn+/Pt-); lanes 14 and 15, I974 (Prn-/Pt+).
Figure 2
Figure 2
Map of the 28-kb region deleted in Bordetella pertussis strains I979 and FR3749, compared with vaccine strain Tohama I. Vertical lines indicate the deletion boundaries, at a nucleotide G of the IS481 6-base insertion site motif. The deleted region is flanked by a single IS481 on each end in Tohama I and FR3749; I979 contains a second tandem IS481 downstream of the deletion. In Tohama I, IS1002 is located in the deletion region immediately upstream of IS481, and they share the 6-base motif.

References

    1. Misegades LK, Winter K, Harriman K, Talarico J, Messonnier NE, Clark TA, et al. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA. 2012;308:2126–32. 10.1001/jama.2012.14939 - DOI - PubMed
    1. Pawloski LC, Queenan AM, Cassiday PK, Lynch AS, Harrison MJ, Shang W, et al. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clin Vaccine Immunol. 2014;21:119–25 . 10.1128/CVI.00717-13 - DOI - PMC - PubMed
    1. Bowden KE, Williams MM, Cassiday PK, Milton A, Pawloski L, Harrison M, et al. Molecular epidemiology of the pertussis epidemic in Washington State in 2012. J Clin Microbiol. 2014;52:3549–57. 10.1128/JCM.01189-14 - DOI - PMC - PubMed
    1. Bouchez V, Brun D, Cantinelli T, Dore G, Njamkepo E, Guiso N. First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin. Vaccine. 2009;27:6034–41. 10.1016/j.vaccine.2009.07.074 - DOI - PubMed
    1. Probert WS, Ely J, Schrader K, Atwell J, Nossoff A, Kwan S. Identification and evaluation of new target sequences for specific detection of Bordetella pertussis by real-time PCR. J Clin Microbiol. 2008;46:3228–31. 10.1128/JCM.00386-08 - DOI - PMC - PubMed

Publication types

MeSH terms